AVITA Medical Inc.

NASDAQ: RCEL · Real-Time Price · USD
5.73
-0.07 (-1.21%)
At close: Aug 15, 2025, 12:14 PM

AVITA Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-61.84M -35.38M -26.66M -25.14M
Depreciation & Amortization
1.13M 632K 568K 969K
Stock-Based Compensation
13.5M 8.38M 7M 6.33M
Other Working Capital
1.31M -386K -122K -391K
Other Non-Cash Items
2.96M -5.07M 1.21M 1.53M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-4.68M -6.57M -1.2M -1.73M
Operating Cash Flow
-48.94M -38.01M -19.09M -18.04M
Capital Expenditures
-9.33M -1.45M -525K -487K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-24.5M -78.76M -74.36M n/a
Sales Maturities Of Investments
71.2M 81.81M 55.55M n/a
Other Investing Acitivies
-162K -66K -73K -49.72M
Investing Cash Flow
37.36M 1.61M -19.33M -50.21M
Debt Repayment
n/a 38.76M n/a -11K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.51M 1.61M 900K 64.08M
Financial Cash Flow
3.51M 40.37M 900K 64.06M
Net Cash Flow
-8.07M 3.95M -37.55M 37.11M
Free Cash Flow
-58.27M -39.46M -19.61M -18.52M